• "Vascular tuft sign" in neuroendocrine tumors of the pancreas
• A cross-species transcriptomic analysis reveals a novel 2-dimensional classification system explaining the invasiveness heterogeneity of pancreatic neuroendocrine tumor
• A Neuroendocrine Biomarker Revolution From Monoanalyte to Multianalyte Biomarkers in Non-Functioning Gastro-entero-pancreatic Neuroendocrine Neoplasms
• A Neuroendocrine Tumor of Unknown Primary Origin: A Case Report and Review of the Literature
• A novel endoscopic ultrasomics-based machine learning model and nomogram to predict the pathological grading of pancreatic neuroendocrine tumors
• A novel model for predicting postoperative liver metastasis in R0 resected pancreatic neuroendocrine tumors: integrating computational pathology and deep learning-radiomics
• A pilot study of the immune microenvironment of GI neuroendocrine carcinoma
• A real-world pharmacovigilance study of FDA adverse event reporting system (FAERS) events for sunitinib
• Absence of PNET formation and normal longevity in a mouse model of Mahvash disease
• Acute pancreatitis as the initial manifestation of an ampullary neuroendocrine tumor
• Appendicular Neuroendocrine Tumours: An Unusual Cause of Hydronephrosis
• ARX, PDX1, ISL1 and CDX2 expression distinguishes five subgroups of PanNETs with correlations to histology, hormone expression and outcome
• ASO Author Reflections: Prognostic Value of Subgrading G2 Pancreatic Neuroendocrine Tumors as 2A versus 2B
• Association Between Female Sex and Better Survival in Gastroenteropancreatic Neuroendocrine Tumors
• Autoimmune Pancreatitis Mimicking Obstructive Pancreatic Neuroendocrine Tumor
• Case report: Comprehensive follow-up of a Colombian family carrying a novel MEN1 variant linked to a rare ACTH-producing pancreatic neuroendocrine carcinoma
• Characteristics and risk differences of different tumor sizes on distant metastases of pancreatic neuroendocrine tumors: A retrospective study in the SEER database
• Characteristics, therapy, and outcome of rare functioning pancreatic neuroendocrine neoplasms
• Chemical complementarity of tumor resident, T-cell receptor CDR3s and renalase-1 correlates with increased melanoma survival
• Childhood pancreatic neuroendocrine neoplasms: A national experience
• Chromothripsis is a novel biomarker for prognosis and differentiation diagnosis of pancreatic neuroendocrine neoplasms
• Clinical feasibility of duodenum-preserving pancreatic head resection for neuroendocrine tumors of the pancreatic head as an intermediate procedure between enucleation and pancreaticoduodenectomy
• Clinicopathological Features of Pediatric Insulinoma: A Single-Centre Study
• Comments and illustrations of the European Federation of Societies for Ultrasound in Medicine guidelines: Rare pancreatic tumors, ultrasound and contrast-enhanced ultrasound features-Malignant mesenchymal tumors
• Comparative Analysis of Complications Following Distal Resections for Neuroendocrine Tumors and Adenocarcinoma: Unveiling the Differences
• Comparative analysis of international guidelines on the management of advanced non-functioning well-differentiated pancreatic neuroendocrine tumors
• Comparison among different preclinical models derived from the same patient with a non-functional pancreatic neuroendocrine tumor
• Critical appraisal of the adequacy of surgical indications for non-functioning pancreatic neuroendocrine tumours
• Cure after surgery for hepato-pancreato-biliary cancers: A systematic review
• Current and Emerging Applications of Artificial Intelligence (AI) in the Management of Pancreatobiliary (PB) disorders
• Cylindrical TGR as early radiological predictor of RLT progression in GEPNETs: a proof of concept
• Development of 3D-iNET ORION: a novel, pre-clinical, three-dimensional in vitro cell model for modeling human metastatic neuroendocrine tumor of the pancreas
• Diagnostic Modalities, Management Considerations, and Outcomes of Insulinoma: A Case Series from a Tertiary Care Centre
• Distinct clinicopathological features of neuroendocrine liver metastases originating from the pancreas and rectum
• Early detection of multiple endocrine neoplasia type 1: A case report
• Endoscopic ultrasonography for microvascular imaging without contrast enhancement in the differential diagnosis of pancreatic lesions
• Endoscopic ultrasonography-based intratumoral and peritumoral machine learning radiomics analyses for distinguishing insulinomas from non-functional pancreatic neuroendocrine tumors
• Enhancing [¹⁷⁷Lu]Lu-DOTA-TATE therapeutic efficacy in vitro by combining it with metronomic chemotherapeutics
• Enhancing precision: A predictive model for (177)Lu-DOTATATE treatment response in neuroendocrine tumors using quantitative (68)Ga-DOTATATE PET and clinicopathological biomarkers
• European Neuroendocrine Tumor Society (ENETS) 2024 guidance paper for the management of well-differentiated small intestine neuroendocrine tumours
• Evaluation and Surgical Management of Multiple Endocrine Neoplasias
• Expression profiles of cadherin 17 and claudin 18.2 in comparison with peptide hormonal expression in pancreatic neuroendocrine tumours: Implications for targeted immunotherapy
• Extrahepatic biliary neuroendocrine tumors: A national cancer database analysis
• Fulminant hypercorticism due to ACTG producing pheochromocytoma
• Functional Copy-Number Alterations as Diagnostic and Prognostic Biomarkers in Neuroendocrine Tumors
• Gangliocytic paraganglioma: A case report
• Gastro-entero-pancreatic neuroendocrine neoplasms (GEP-NENs) - Current literature review of diagnostics and therapy. What has changed in the management?
• Gastroenteropancreatic neuroendocrine tumors in children and adolescents
• Gut microbiota and pancreatic cancer risk, and the mediating role of immune cells and inflammatory cytokines: a Mendelian randomization study
• Histo- and molecular pathology in gastroenteropancreatic neuroendocrine neoplasms
• Implications of noncoding regulatory functions in the development of insulinomas
• In vivo interaction screening reveals liver-derived constraints to metastasis
• Initial validation of the clinical significance of the NETest in Japanese gastroenteropancreatic neuroendocrine tumor patients
• Innovative imaging approaches for neuroendocrine tumor characterization: Combined dual energy CT and perfusion protocol implementation
• INSM1 expression in neuroendocrine tumors in a tertiary care hospital
• Intraductal and cystic pancreatic neoplasia
• Liquid-based cytology features of pancreatic acinar cell carcinoma: comparison with other non-ductal neoplasms of the pancreas
• Management of advanced high grade gastro-enteropancreatic neuroendocrine neoplasms (GEP-NENs): comprehensive review of the current literature
• Management of Pancreatic Neuroendocrine Tumors (PNETs): Surgical strategies and controversies
• Management of Pancreatic Neuroendocrine Tumors: Surgical Strategies and Controversies
• MEN1 Deficiency-Driven Activation of the beta-Catenin-MGMT Axis Promotes Pancreatic Neuroendocrine Tumor Growth and Confers Temozolomide Resistance
• MEN1/DAXX/ATRX mutations enhance progression-free survival in gastroenteropancreatic neuroendocrine tumors treated with peptide receptor radionuclide therapy
• Metabolic Tumor Volume on 18-Fluorodeoxyglucose Positron Emission Tomography as a Prognostic Marker of Survival in Patients With Locally Advanced or Metastatic Neuroendocrine Neoplasms Treated With 177Lutetium-DOTA-Octreotate Peptide Receptor Radionuclide
• miRNA Expression Profiling in G1 and G2 Pancreatic Neuroendocrine Tumors
• Mixed hepatocellular carcinoma and high-grade neuroendocrine neoplasm with ambiguous histopathological features: a case report
• Molecular and Clinicopathologic Impact of GNAS Variants Across Solid Tumors
• MUC1-C Dependence for the Progression of Pancreatic Neuroendocrine Tumors Identifies a Druggable Target for the Treatment of This Rare Cancer
• Necrolytic migratory erythema caused by pancreatic hyperglycemia with emphasis on therapeutic and prognosis: A case report
• Neoadjuvant Capecitabine Plus Temozolomide in Atypical Lung NETs
• Neuroendocrine Neoplasms
• Nivolumab plus platinum-doublet chemotherapy in treatment-naive patients with advanced grade 3 Neuroendocrine Neoplasms of gastroenteropancreatic or unknown origin: The multicenter phase 2 NICE-NEC trial (GETNE-T1913)
• Occult Pancreatic Neuroendocrine Tumor Presenting as Carcinoid Syndrome
• Oncogenic pathway signatures predict the risk of progression and recurrence in well-differentiated pancreatic neuroendocrine tumors
• Outcome of Endoscopic Resection of Rectal Neuroendocrine Tumors 10 mm
• Outcomes Analysis of 90Y Radioembolization for Tumors Other Than Metastatic Colorectal Cancer from the RESiN (Radiation-Emitting SIR-spheres in Non-resectable liver tumors) Registry
• Overcome intraoperative difficulties of ALPPS procedure: a single-center outcomes and technical experience
• Pancreatic and Ileal Neuroendocrine Tumors: Metastatic Disease or a Novel MEN Syndrome?
• Pancreatic Insulinoma Masquerading as Neurological Disease: Diagnosis and Treatment of a Rare Tumor
• Pancreatic neuroendocrine tumor with abundant mitochondria
• Parathyroid Hormone-Related Peptide Secretion From a Pancreatic Neuroendocrine Tumor: A Rare Case Report of Severe Hypercalcemia
• PAX8 expression in cancerous and non-neoplastic tissue: a tissue microarray study on more than 17,000 tumors from 149 different tumor entities
• PCSK2 can be Useful in a Panel Approach to Distinguish Foregut and Midgut Neuroendocrine Tumors
• Portuguese Pancreatic Club Perspectives on Endoscopic Ultrasound-Guided and Surgical Treatment of Pancreatic Neuroendocrine Tumors
• Preoperative Prediction of Lymph Node Metastases in Nonfunctional Pancreatic Neuroendocrine Tumors Using a Combined CT Radiomics-Clinical Model
• Prevalence, distribution, and prognostic significance of morphological variants of neuroendocrine tumors of the gastrointestinal tract - a multicenter study
• Progresses and hot spots of gastroenteropancreatic neuroendocrine neoplasms
• Proteomic analysis of differentially expressed proteins in gastrointestinal neuroendocrine tumors and their liver metastasis
• Rapid response to selpercatinib in RET fusion positive pancreatic neuroendocrine carcinoma confirmed by smartwatch
• Rare tumors II: Adrenocortical tumors, neuroendocrine tumors of the appendix, pheochromocytoma and paraganglioma, pancreatoblastoma and solid pseudopapillary tumors of the pancreas
• Robotic Spleen-Preserving Distal Pancreatectomy: The Warshaw and Kimura Techniques
• Safety and Efficacy of Peptide Receptor Radionuclide Therapy (PRRT) Following Bland Embolization for Metastatic Neuroendocrine Tumors
• Sarcopenia in Patients with Advanced Gastrointestinal Well-Differentiated Neuroendocrine Tumors
• SCG2 and CPE may be novel markers for the identification of pancreatic neuroendocrine tumors and solid pseudopapillary neoplasms
• Single Stage Bilateral Adrenalectomy (Cortical-Sparing) and Pancreatectomy (Corpus-Sparing) in a Patient with Von Hippel-Lindau Disease
• Subgrading of G2 Pancreatic Neuroendocrine Tumors as 2A (Ki67 3% to < 10%) Versus 2B (10% to 20%) Identifies Behaviorally Distinct Subsets in Keeping with the Evolving Management Protocols
• Surgery for pancreatic neuroendocrine tumors during the COVID-19 pandemic: a retrospective cohort from a high-volume center
• Surgical management of pancreatic neuroendocrine tumors - An EYSAC and E-AHPBA international survey of current practice
• Systemic treatment of patients with metastatic neuroendocrine Neoplasia
• Trends in the Use of Observation for Small Nonfunctional Pancreatic Neuroendocrine Tumors
• Update in the management of gastroenteropancreatic neuroendocrine tumors